BRD4 and neoplasm: The hydrophobic l‐phenylalanine‐poly(ester amide) nanoparticles (JQ1/THZ1@8P4 NPs) could be loaded with JQ1 (a BRD4 inhibitor) and THZ1 (a CDK7 inhibitor) to target tumor sites.